Div. of Endocrinology and Metabolism Konyang University, School of Medicine. Byung-Joon Kim M.D., Ph.D.

Similar documents
Megan Lawless. Journal Club. January 20 th, 2011

Chief of Endocrinology East Orange General Hospital

Scope. History. History. Incretins. Incretin-based Therapy and DPP-4 Inhibitors

Effect of macronutrients and mixed meals on incretin hormone secretion and islet cell function

The enteroinsular axis in the pathogenesis of prediabetes and diabetes in humans

Practical Strategies for the Clinical Use of Incretin Mimetics CME/CE. CME/CE Released: 09/15/2009; Valid for credit through 09/15/2010

The Role of the Sweet Taste Receptor in Enteroendocrine Cells and Pancreatic β-cells

Discussion & Conclusion

NIH Public Access Author Manuscript Diabetologia. Author manuscript; available in PMC 2014 February 01.

Sweetness and Glycaemic Regulation. (A focus on gut related and physiological aspects) John McLaughlin Manchester University

Overview. Physiology 1. The Gastrointestinal Tract. Guyton section XI

Control of Glucose Metabolism

The Mediterranean Diet: HOW and WHY It Works So Well for T2DM

GLP-1 agonists. Ian Gallen Consultant Community Diabetologist Royal Berkshire Hospital Reading UK

Physiology 12. Overview. The Gastrointestinal Tract. Germann Ch 19

ROLE OF TASTE IN METABOLIC CONTROL OF TYPE 1 DIABETES MELLITUS

Type 2 DM in Adolescents: Use of GLP-1 RA. Objectives. Scope of Problem: Obesity. Background. Pathophysiology of T2DM

New and Emerging Therapies for Type 2 DM

The effect of bitter, umami and sweet tastants on the food intake regulation

INJECTABLE THERAPY FOR THE TREATMENT OF DIABETES

Chapter 20 The Digestive System Exam Study Questions

22 Emerging Therapies for

TGR5 activation induces intestinal growth and improves intestinal mucositis in mice. Hannelouise Kissow

Management of Type 2 Diabetes

Therapeutic strategy to reduce Glucagon secretion

Newer and Expensive treatment of diabetes. Endocrinology Visiting Associate Professor Institute of Medicine TUTH

Treatment Options for Diabetes: An Update

Treating Type 2 Diabetes with Bariatric Surgery. Goal of Treating T2DM. Remission of T2DM with Bariatric

Update on GLP-1 Past Present Future

Defects in glucose utilization & GLP-1

Sitagliptin: first DPP-4 inhibitor to treat type 2 diabetes Steve Chaplin MSc, MRPharmS and Andrew Krentz MD, FRCP

For more information about how to cite these materials visit

Role of incretins in the treatment of type 2 diabetes

New Insights into Mechanism of Action

Dose-dependent effect of glucose on GLP-1 secretion involves sweet taste receptor in isolated perfused rat ileum

Genotype analysis by Southern blots of nine independent recombinated ES cell clones by

My Journey in Endocrinology. Samuel Cataland M.D

History of Investigation

GLUCAGON LIKE PEPTIDE (GLP) 1 AGONISTS FOR THE TREATMENT OF TYPE 2 DIABETES, WEIGHT CONTROL AND CARDIOVASCULAR PROTECTION.

Endocrine System. Regulating Blood Sugar. Thursday, December 14, 17

EAT TO LIVE: THE ROLE OF THE PANCREAS. Felicia V. Nowak, M.D., Ph.D. Ohio University COM 22 January, 2008

ENERGY FROM INGESTED NUTREINTS MAY BE USED IMMEDIATELY OR STORED

The Role of Incretins in Glucose Homeostasis and Diabetes Treatment

Disclosure. Learning Objectives. Case. Diabetes Update: Incretin Agents in Diabetes-When to Use Them? I have no disclosures to declare

GLP-1 Receptor Agonists and SGLT-2 Inhibitors. Debbie Hicks

adenosine triphosphate-sensitive K[ Citation Journal of Diabetes Investigation ( modifications or adaptations are ma

Novel anti-diabetic therapies

β-cell Preservation and Regeneration After Islet Transplantation

New Treatments for Type 2 diabetes. Nandini Seevaratnam April 2016 Rushcliffe Patient Forum

The Digestive and Endocrine Systems

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Single Technology Appraisal. Canagliflozin in combination therapy for treating type 2 diabetes

BELLWORK DEFINE: PERISTALSIS CHYME RUGAE Remember the structures of the digestive system 1

Appetite, Glycemia and Entero-Insular Hormone Responses Differ Between Oral, Gastric-Remnant and Duodenal Administration of a Mixed Meal Test After

Digestive System. Digestive System. Digestion is the process of reducing food to small molecules that can be absorbed into the body.

Supplementary Figure 1: Steviol and stevioside potentiate TRPM5 in a cell-free environment. (a) TRPM5 currents are activated in inside-out patches

The Small Intestine. The pyloric sphincter at the bottom of the stomach opens, squirting small amounts of food into your small intestine.

Enrique Caballero, MD Director, Latino Diabetes Initiative Joslin Diabetes Center Harvard Medical School

GLP-1. GLP-1 is produced by the L-cells of the gut after food intake in two biologically active forms It is rapidly degraded by DPP-4.

la prise en charge du diabète de

Bio& 242 Unit 1 / Lecture 4

The important role of umami taste in oral and overall health

Abstract. Effect of sitagliptin on glycemic control in patients with type 2 diabetes. Introduction. Abbas Mahdi Rahmah

Accumulation of intestinal tissue 3 deoxyglucosone attenuated GLP 1 secretion and its insulinotropic effect in rats

DIABETES IN 2007 What snew

2. A digestive organ that is not part of the alimentary canal is the: a. stomach b. liver c. small intestine d. large intestine e.

Bariatric surgery, such as Roux-en-Y gastric bypass

Physiology Unit 4 DIGESTIVE PHYSIOLOGY

Overview of digestion or, gut reactions - to food

An integrated glucose homeostasis model of glucose, insulin, C-peptide, GLP-1, GIP and glucagon in healthy subjects and patients with type 2 diabetes

Gastric By-Pass and Remission of Type II Diabetes in Obese Adults

Metabotropic Receptors and Second Messengers. Direct, ionotropic receptor. ion. There are 2 classes of neurotransmitter receptors:

islets scored 1 week month months

18. PANCREATIC FUNCTION AND METABOLISM. Pancreatic secretions ISLETS OF LANGERHANS. Insulin

Diabetes update - Diagnosis and Treatment

The Effects of Exenatide on the Autoimmune Development of Diabetes. A Senior Honors Thesis

Incretinas e inhibidores de la DPP-4. Dr. Ramon Gomis Hospital Clínic Barcelona

GLP 1 agonists Winning the Losing Battle. Dr Bernard SAMIA. KCS Congress: Impact through collaboration

The Intricate Web Of Hormone Relationships Dr. Ritamarie Loscalzo

Overview of digestion or, gut reactions - to food

Type 2 Diabetes and Cancer: Is there a link?

1.1. An overview of reports on sitagliptin

NUTRIENT DIGESTION & ABSORPTION

The Players. Liver Thyroid Adrenals Pancreas Reproductive System Pituitary Gut Bacteria

DR. SUBHASH K. WANGNOO

Current Status of Incretin Based Therapies in Type 2 Diabetes

Exendin-4-mediated cell proliferation in beta-cells: focusing on the transcription factors

Bariatric Surgery MM /11/2001. HMO; PPO; QUEST 05/01/2012 Section: Surgery Place(s) of Service: Outpatient; Inpatient

Introduction to Human Anatomy & Physiology Chapter 35

Neuroprotective properties of GLP-1 - a brief overview. Michael Gejl Jensen, MD Dept. Of Pharmacology, AU

Growth Hormone, Somatostatin, and Prolactin 1 & 2 Mohammed Y. Kalimi, Ph.D.

Diabetes 2013: Achieving Goals Through Comprehensive Treatment. Session 2: Individualizing Therapy

T2DM is a global epidemic with

What s New on the Horizon: Diabetes Medication Update

Gamma-aminobutyric acid (GABA) treatment blocks inflammatory pathways and promotes survival and proliferation of pancreatic beta cells

INJECTABLE THERAPIES IN DIABETES. Barbara Ann McKee Diabetes Specialist Nurse

Therapy: Metformin takes a new route to clinical

Foregut Exclusion Disrupts Intestinal Glucose Sensing and Alters Portal Nutrient and Hormonal Milieu

type 2 diabetes is a surgical disease

What s New in Diabetes Treatment. Disclosures

Transcription:

Diabetes and Thyroid Center Div. of Endocrinology and Metabolism Konyang University, School of Medicine Byung-Joon Kim M.D., Ph.D.

Background Incretin effect and GLP 1 Receptor in L cells TGR5 receptor GPR120 receptor Taste receptor in tongue Taste receptor in gut (enteroendocrine cells) GLP 1 secretion through Taste receptor via sweet receptor via bitter receptor Summary and Conclusion

Venous Plasma Glucose (mg/dl) 200 20 2.0 Oral Glucose IV Glucose /L) e (nmol 100 1.0 C peptid * 15 1.5 * Incretin Effect 0 00 0.0 0 1 Glucose 0 2 60(or food) 120stimulated 180 Insulinotropic 0 1 0 2 60 hormones 120 180 Time (min) Time (min) 0.5 from enteroendocrine cells. * * * * * Same blood glucose level by oral or IV route Two candidate hormones are GLP 1 and GIP. Different insulin response Mean ± SE; N=6; *p.05; 0 1 0 2 =glucose infusion time. Nauck MA. et al. J Clin Endocrinol Metab. 63:492 498. 1986

Stimulates insulin Secretion Potentiates glucose induced insulin secretion Enhanced all steps of insulin secretion Up regulation of insulin gene expression Up regulation of genes essential for the beta cell function Increases Islet mass Beta cells proliferation Promotes differentiation of ductal progenitor cells Inhibits apoptosis Stimulated somatostatin secretion Inhibits glucagon secretion Extrapancreatic effects p Inhibits gastrointestinal secretion and motility Inhibits appetite and food intake Cardiovascular effects

Modification of GLP 1 peptide GLP 1 Analog Exendin 4 liraglutide GLP 1 Good for T2DM Limitation: Short half life Block the Enzyme activity DPPIV inhibitor Sitagliptin Vildagliptin Saxagliptin Stimulation of GLP 1 secretion GLP 1 Secretagogues

1 2 1) directly monitored nutrients via the receptors/transporters in cell surface 2) via gastroenteric nervous system and/or extrinsic nervous system 3) via paracrine manner Buchan AM. et al. Am J Physiol, 277: G1103 7, 1999

TGR5 receptor G protein coupled receptor (GPCR) responds to bile acids expressed in monocytes/macrophages intestinal cell lines, NCI H716 and STC 1 Lithocholic acid (LCA) Deoxycholic acid (DCA) Northern blot Analysis Internalization of TGR5 receptor After treatment of LCA (TGR5/GFP CHO cells) T. Maruyama et al. Biochem. Biophys. Res. Commun. 298 :714 719, 2002 K. Susumu et al. Biochem. Biophys. Res. Commun. 329:386 390, 2005

GPR120 receptor An orphan G protein coupled receptor Responced to fatty acid Expression in intestinal tract in mouse and human α-linolenic (α-la) In situ hybridization for GPR120 (ISH) immunohistochemistry with antibody to GLP 1 (IHC) A. Hirasawa et al. Nat Med. 11: 90 4, 2005

Taste Sencing Signal pathway for taste receptor

Umami sense Bitter sense Sour sense Salty sense Sweet sense

Sweet sugar sweetner Bitter denatoneum PTU Taste signals Taste receptor Gα gustducin Gβ3 Gγ13 PLCβ2 TRPM 5

Taste receptor Alpha gustducin TRMP5 calcium channel PLC β2

GLP 1 α gustducin Merge α gustducin GFP transgenic mice Duodenum Jejunum Ileum α gustducin is co expressed with GLP 1 in the small intestine L cells.

Element GLP-1 Merge Element GLP-1 Merge

Sweet receptor Heterodimeric i receptor T1R2 + T1R3

Glucose gavage 10% glucose loading in Isolated duodenal villi Blunted GLP 1secretion in a gustducin null mice after glucose gavage (5 g/kg) and ex vivo glucose loading. Jang HJ, Kim BJ, Egan JM. Proc Natl Acad Sci U S A 104:15069 15074, 2007

Blunted insulin secretion and higher glucose levels in a gustducin null mice after glucose gavage (2 g/kg). Jang HJ, Kim BJ, Egan JM. Proc Natl Acad Sci U S A 104:15069 15074, 2007

Coupling of taste receptors to G protein α subunits with [ 32 P] GTP azidoanilide NCI H716 cells Jang HJ, Kim BJ, Egan JM. Proc Natl Acad Sci U S A 104:15069 15074, 2007

NCI H716 cells Intracellular calcium is increased by external calcium loading

NCI H716 cells Lactisole: sweet receptor inhibitor Jang HJ, Kim BJ, Egan JM. Proc Natl Acad Sci U S A 104:15069 15074, 2007

A: antrum C: colon F: fundus L: liver D: duodenum H: heart I: ileum; K: kidney J: jejunum T: tongue Individual id ltrace of f[ca 2 ]i from a single STC 1 cell exposed to 10mM denatonium benzoate (DB). Wu SV, et al. Proc Natl Acad Sci U S A 99:2392 2397, 2002

Kim BJ unpublished data

Sweet ttaste t receptor and dits signal element existed din the GLP 1 producing L cells in intestine. After treatment of glucose, alpha gustducin is activated and intracellular calcium increased via sweet receptor. Glucose and sweetner can be increased GLP 1 secretion through sweet receptor. Bitter taste receptor also expressed in GLP 1 secreting L cells. Bitter compound can increase GLP 1 secretion.

Gut, L cells, can sense the sweet and bitter taste through its receptor. GLP 1 secretion was stimulated through sweet and bitter taste receptor.

Work with NIA/NIH Mount Sinai i School of Medicine i Hyeung Jin Jang Zaza Kokrashvili Michael J. Theodorakis Bedrich Mosinger Olga D. Carlson Robert F. Margolskee Jie Zhou Hyeon Ho Kim Xiangru Xu Sic L. Chan, Magdalena Juhaszova Michel Bernier Josephine M. Egan